Pramiconazole

Pramiconazole
Clinical data

ATC code	none
Identifiers
IUPAC name 1-{4-[4-(4-{[(2R,4S)-2-(2,4-difluorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazin-1-yl]phenyl}-3-isopropylimidazolidin-2-one
PubChem CID	3013050 11411233
ChemSpider	2281806^N
UNII	4SYH0R661F
ChEMBL	CHEMBL175797^N
Chemical and physical data
Formula	C₃₅H₃₉F₂N₇O₄
Molar mass	659.725 g/mol
3D model (JSmol)	Interactive image
SMILES CC(C)N1CCN(C1=O)c2ccc(cc2)N3CCN(CC3)c4ccc(cc4)OC[C@H]5OC[C@](O5)(Cn6cncn6)c7ccc(cc7F)F
InChI InChI=1S/C35H39F2N7O4/c1-25(2)43-17-18-44(34(43)45)29-6-4-27(5-7-29)40-13-15-41(16-14-40)28-8-10-30(11-9-28)46-20-33-47-22-35(48-33,21-42-24-38-23-39-42)31-12-3-26(36)19-32(31)37/h3-12,19,23-25,33H,13-18,20-22H2,1-2H3/t33-,35+/m0/s1^N Key:AEKNYBWUEYNWMJ-QWOOXDRHSA-N^N
^NY (what is this?)

Pramiconazole is a triazole antifungal undergoing research for the treatment of acute skin and mucosal fungal infections.

It is developed by Barrier Therapeutics.